Market Insights with Gary Thomson: US Inflation Rate and Producer Price Index, BoC Interest Rate
FXOpen
In this video, we’ll explore the key economic events, market trends, and corporate news shaping the financial landscape. Get ready for expert insights into forex, commodities, and stocks to help you navigate the week ahead. Let’s dive in!
In this episode, we discuss:
- US Inflation Rate
The US inflation report on Wednesday could impact markets ahead of the Fed meeting. Will it reinforce dollar strength or bring surprises? - BoC Interest Rate Decision
The Bank of Canada’s rate decision on Wednesday could bring market volatility. Will the press conference hint at further cuts? - US Producer Price Index
The Producer Price Index is out on Thursday—will it confirm easing inflation or bring another upside surprise?
Don’t miss out—gain insights to stay ahead in your trading journey.
Watch it now and stay updated with FXOpen.
This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
Stay ahead of the market!
Subscribe now to our mailing list and receive the latest market news and insights delivered directly to your inbox.
Latest articles
CAD/JPY: The Yen's Most Historic Move in 30 Years Meets a Fragile Support
Two central banks are heading in genuinely opposite directions this week, and the tension is unmistakable. The Bank of Canada held rates steady at 2.25% on September 2, with a mildly hawkish tilt as policymakers acknowledged a broadening economic
USD/JPY and USD/CAD Await Key Fed Decision
The US dollar is consolidating against the yen and Canadian dollar ahead of the key event of the week — the Federal Reserve meeting. The Fed is widely expected to raise its policy rate by 25 basis points to a range
UnitedHealth: Fundamentals Are Healing, Now the Chart Must Agree
UnitedHealth finds itself in a genuinely split narrative right now, trading near $388, down about 15.9% from its 52-week high, even as the fundamental picture keeps improving. Q2 earnings beat expectations, with revenue of $112.03 billion, and the